RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

<<It is a shame to snuff that out for the sake of expedience. >>

Wait a minute. While I strongly dislike Pharma label-expansion at any cost policies, which are hardly limited to Lilly, the notion that antipsychotics are used for simple "expedience" in the management of elderly patients with dementia is off-base. Families--and Alzheimer's units--don't have a lot of options with dementia patients who have become paranoid, agitated, and delusional due to the dementia. And the paranoia/delusional thinking can show up pretty early in the course of the disease, if anything, people with late-stage dementia no longer have the cognitive wherewithal to be paranoid. Having said that, I also have no doubt that some understaffed nursing homes probably overuse meds to tranquilize patients, particularly with the 'sundown effect', where dementing patients often seem worse late in the day, when there are usually fewer staff available. But not all antipsychotic use in dementia should be tarred with that brush.

NeuroInvestment